Kensington Senior Living is proud to present Care. Cure. Prevent., a virtual panel on everything brain health including the care, cure and prevention of Alzheimer’s disease.
Lauren Miller Rogen of HFC leads this dynamic panel as they share the latest breakthroughs in Alzheimer’s research and treatment options. They discuss the impact of brain disease on families, what to do after diagnosis, and how to manage challenges that commonly result from changing family dynamics. They offer recommendations about lifestyle habits that can help reduce the risk of memory loss and other degenerative brain diseases.
This event is in collaboration with Cedars Sinai, UCLA, USC, Stanford, and Ray Dolby Brain Health Center with a panel discussion moderated by Lauren Miller Rogen.
Learn more about:
- Exploring the human factor of Alzheimer’s disease, the myths vs. the facts.
- What to do after receiving a dementia or Alzheimer’s diagnosis.
- How to prevent Alzheimer’s disease and the impact of hereditary risk factors.
- Recent breakthroughs in research, treatments, and blood test diagnosis.
- How will the Biogen drug approval will impact our community.
- Navigating family dynamics and overcoming caregiver challenges.
All of us at Kensington Senior Living thank our professional partners who generously share knowledge that helps keep our care and services current. We encourage event attendees to visit our websites to explore our comprehensive spectrum of programming and support for all who are affected by memory loss.
The Moderator:
Lauren Miller Rogen, Co-Founder, HFC is a screenwriter, director, producer, and philanthropist, whose life has been touched many times over by Alzheimer’s. In 2012—when Lauren’s mother was diagnosed with early-onset Alzheimer’s disease at just 55 years old— Lauren, still in her twenties, co-founded HFC to activate the next generation of Alzheimer’s advocates. Since then, Lauren and the HFC team have brought significant awareness to Alzheimer’s, raising millions of dollars to award free, quality in-home care to families in need of respite and support – all while using humor and hope to engage people. Her dedication to sharing her personal story and using humor as a form of advocacy has left an indelible impact on the Alzheimer’s space. Since 2013, Lauren has served as the Alzheimer’s patient advocate on the board of California’s Institute of Regenerative Medicine (CIRM). She also sits on the California Alzheimer’s Task Force and the Steering Committee of the Milken Institute’s Alliance to Improve Dementia Care. In 2012, Lauren starred in, co-wrote, and produced the film For A Good Time Call, which premiered at the 2012 Sundance Film Festival. She made her feature-length directorial debut in 2018 with the “dramedy” Like Father, a film she wrote and which starred Kristen Bell and Kelsey Grammer. If there is one thing Lauren wants people to remember, it’s that Alzheimer’s doesn’t have to be sad or scary when you’re fighting against it. You can come to an HFC event and have fun, but also do something for Alzheimer’s.
The Speakers:
Dr. Irina Anna Skylar-Scott is a Board-Certified, Fellowship-TrainedCognitive and Behavioral Neurologist and Clinical Assistant Professor at Stanford University. She is a Diplomate of the American Board of Psychiatry and Neurology as well as the United Council for Neurologic Subspecialties in Behavioral Neurology and Neuropsychiatry.
Dr. Travis Urban is a Cognitive Neurologist and the Associate Director of the Ray Dolby Brain Health Center. He received his medical degree from the University of Texas Medical Branch and completed his internship at Stanford University. In his clinical practice, he sees patients with cognitive impairment like Alzheimer’s disease, Lewy body disease, and frontotemporal degeneration.
Dr. Doris Molina-Henry is an Assistant Professor of Research in the Department of Neurology at the University of Southern California’s Keck School of Medicine for the Alzheimer’s Therapeutic Research Institute. She is part of the leadership at the Alzheimer’s Therapeutic Research Institute in San Diego. Her work is focused on the science of clinical trial recruitment and retention of diverse participants into clinical trials. Currently, she works on evaluating strategies that promote participation in clinical trials that aim to help prevent the symptoms of Alzheimer’s well before they begin in individuals who are cognitively healthy but are at high risk for the disease in the future.
Dr. Sarah Kremen is a behavioral neurologist and the Director of the Neurobehavior Program at the Jona Goldrich Center for Alzheimer’s and Memory Disorders at Cedar-Sinai Medical Center. She sees patients with memory, language and other cognitive disorders due to Alzheimer’s and other neurodegenerative diseases. Her research has focused on clinical trials and observational studies of people at risk of developing Alzheimer’s and those already diagnosed with mild cognitive impairment and dementia due to Alzheimer’s.
Dr. Leila Parand is the Assistant Clinical Professor of Neurology at the Mary S. Easton Center for Alzheimer’s Research and Care at the University of California, Los Angeles. Her specialties include Neurology, Alzheimer’s Disease, Memory Disorders, and Dementia.
In Partnership with:
